These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 12113054)

  • 1. Gene therapy for prostate cancer.
    Gdor Y; Timme TL; Miles BJ; Kadmon D; Thompson TC
    Expert Rev Anticancer Ther; 2002 Jun; 2(3):309-21. PubMed ID: 12113054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I study of replication-competent adenovirus-mediated double suicide gene therapy for the treatment of locally recurrent prostate cancer.
    Freytag SO; Khil M; Stricker H; Peabody J; Menon M; DePeralta-Venturina M; Nafziger D; Pegg J; Paielli D; Brown S; Barton K; Lu M; Aguilar-Cordova E; Kim JH
    Cancer Res; 2002 Sep; 62(17):4968-76. PubMed ID: 12208748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current progress in suicide gene therapy for cancer.
    Yazawa K; Fisher WE; Brunicardi FC
    World J Surg; 2002 Jul; 26(7):783-9. PubMed ID: 11948367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Gene therapy].
    Gotoh A; Shirakawa T; Wada Y; Hinata N; Terao S; Hara I; Arakawa S; Kamidono S; Okada H; Takenaka A; Fujisawa M
    Hinyokika Kiyo; 2005 Feb; 51(2):75-9. PubMed ID: 15773357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data.
    Teh BS; Ayala G; Aguilar L; Mai WY; Timme TL; Vlachaki MT; Miles B; Kadmon D; Wheeler T; Caillouet J; Davis M; Carpenter LS; Lu HH; Chiu JK; Woo SY; Thompson T; Aguilar-Cordova E; Butler EB
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1520-9. PubMed ID: 15050332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Suicide gene therapy for prostate cancer--update of current development].
    Ebara S; Nasu Y
    Nihon Rinsho; 2003 Jul; 61(7):1257-65. PubMed ID: 12877094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
    Ebara S; Shimura S; Nasu Y; Kaku H; Kumon H; Yang G; Wang J; Timme TL; Aguilar-Cordova E; Thompson TC
    Prostate Cancer Prostatic Dis; 2002; 5(4):316-25. PubMed ID: 12627218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prostate cancer gene therapy].
    Nasu Y; Kumon H
    Nihon Rinsho; 2005 Feb; 63(2):335-8. PubMed ID: 15714988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene therapy for prostate cancer.
    Hrouda D; Perry M; Dalgleish AG
    Semin Oncol; 1999 Aug; 26(4):455-71. PubMed ID: 10482188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical application for gene therapy in prostate cancer].
    Gotoh A; Kamidono S; Chung LW
    Hinyokika Kiyo; 1997 Nov; 43(11):829-33. PubMed ID: 9436031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regression of prostate cancer xenografts by a lentiviral vector specifically expressing diphtheria toxin A.
    Zheng JY; Chen D; Chan J; Yu D; Ko E; Pang S
    Cancer Gene Ther; 2003 Oct; 10(10):764-70. PubMed ID: 14502229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Function and therapeutic implication of C-CAM cell-adhesion molecule in prostate cancer.
    Lin SH; Pu YS
    Semin Oncol; 1999 Apr; 26(2):227-33. PubMed ID: 10597733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developments in suicide genes for preclinical and clinical applications.
    Spencer DM
    Curr Opin Mol Ther; 2000 Aug; 2(4):433-40. PubMed ID: 11249774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting of prostate cancer cells by a cytotoxic lentiviral vector containing a prostate stem cell antigen (PSCA) promoter.
    Petrigliano FA; Virk MS; Liu N; Sugiyama O; Yu D; Lieberman JR
    Prostate; 2009 Sep; 69(13):1422-34. PubMed ID: 19489029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is gene therapy the answer for prostate cancer?
    Patel P; Ashdown D; James N
    Prostate Cancer Prostatic Dis; 2004 Sep; 7 Suppl 1():S14-9. PubMed ID: 15365577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In situ gene therapy for prostate cancer.
    Thompson TC
    Oncol Res; 1999; 11(1):1-8. PubMed ID: 10451026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prostate cancer gene therapy].
    Nasu Y; Abarzua F; Kumon H
    Nihon Rinsho; 2005 Dec; 63 Suppl 12():544-7. PubMed ID: 16416850
    [No Abstract]   [Full Text] [Related]  

  • 18. Metastasis suppression: the evolving role of metastasis suppressor genes for regulating cancer cell growth at the secondary site.
    Kauffman EC; Robinson VL; Stadler WM; Sokoloff MH; Rinker-Schaeffer CW
    J Urol; 2003 Mar; 169(3):1122-33. PubMed ID: 12576866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combinational adenovirus-mediated gene therapy and dendritic cell vaccine in combating well-established tumors.
    Xia D; Moyana T; Xiang J
    Cell Res; 2006 Mar; 16(3):241-59. PubMed ID: 16541123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic delivery of enzymes for cancer therapy.
    Deonarain MP; Spooner RA; Epenetos AA
    Gene Ther; 1995 Jun; 2(4):235-44. PubMed ID: 7552983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.